期刊文献+

IL-36a和IL-36R在系统性红斑狼疮皮损中的表达及意义 被引量:3

Expression and clinical significance of IL-36a and IL-36R in skin lesions of systemic lupus erythematosus
下载PDF
导出
摘要 目的观察系统性红斑狼疮(SLE)患者皮损中IL-36β、IL-36R表达。方法应用免疫组化技术检测13例SLE患者皮损和8例对照者皮肤中IL-36、IL-36R分布及表达水平。结果 SLE患者皮损中表皮角质形成细胞、真皮浅层浸润的淋巴细胞核表达IL-36、IL-36R水平较对照组高(P<0.01)。结论 SLE患者皮损中存在IL-36和IL-36R高表达,可能参与SLE发病。 Objective To investigate the lesional expression of IL-36 a and IL-36 R in patients with systemic lupus erythematosus(SLE). Methods The expression of IL-36 a and IL-36 R was examined by immunohistochemistry method in skin lesions of 13 SLE patients and normal skin of 8 healthy controls. Results Compared with normal skin, expression of IL-36 a and IL-36 R in epidermal keratinocytes and infiltrated lymphocytes in the superficial dermis increased in skin lesions(P〈0.01). Conclusion The overexpression of IL-36 a and IL-36 R in skin lesions may be involved in the pathogenesis of SLE.
出处 《广东医学院学报》 2014年第4期450-451,457,共3页 Journal of Guangdong Medical College
关键词 系统性红斑狼疮 白介素36 细胞因子 systemic erythematosus lupus interleukin-36 cytokine
  • 相关文献

参考文献13

  • 1Graham R R, Hom G, Ortmann W, et al. Review of recent genome wide association scans in lupus[J]. J Intern Med, 2009, 265(6):680- 688.
  • 2Enzler T, Bonizzi G, Silverman G J, et al. GJAlternative and classical NF-κB signaling retain autoreactive B cells in the Splenic Marginal Zone and result in Lupus-like Disease[J]. Immunity September, 2006, 25(3):403-415.
  • 3Kumar S, McDonnell P C, Lehr R, et al. Identification and initial characterization of four novel members of the interleukin- 1 family[J]. J Biol Chem, 2000, 275 (14): 10308-10314.
  • 4Apostolidis S A, Lieberman L A, Kis-Toth K, et al. The dysregulation of cytokine networks in systemic lupus erythematosus[J]. J Interferon Cytokine Res, 2011, 31 (10): 769-779.
  • 5Vigne S, Palmer G, Lamacchia C, et al. IL-36R ligands are potent regulators of dendritic and T cells[J]. Blood, 2011, 118(22):5813- 5823.
  • 6Debets R, Timans J C, Homey B, et al. Two novel IL-1 family mem- bers, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL- 1 receptor- related protein 2[J]. J Immunol, 2001, 167(3): 1440-1446.
  • 7Magne D, Palmer G, Barton J L, et al. The new IL-1 family member IL- 1 F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes[J]. Arthritis Res Ther, 2006, 8(3):R80.
  • 8Johnston A, Xing X, Guzman A M, et al. IL-1F5, -F6, -F8, and -F9:a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression[J].J Immunol 2011,186(4):2613-2622.
  • 9Tortola L, Rosenwald E, Abel B, et al. Psoriasiform dermatitis is driven by IL-36- mediated DC-keratinocyte crosstalk[J]. J Clin Invest, 2012, 122(11):3965-3976.
  • 10Smith D E, Renshaw B R, Ketchem R R, et al. Four new members expand the interleukin-1 superfamily[J]. J Biol Chem, 2000, 275(2): 1169-1175.

二级参考文献14

  • 1吴铁,李青南,胡彬,李朝阳,黄连芳,崔燎.壮骨胶囊防治类固醇大鼠肾阳虚的实验研究[J].中国骨质疏松杂志,1999,5(4):76-82. 被引量:13
  • 2吴铁,崔燎,陈志东,张志平,廖进民,李青南,黄连芳.壮骨肾宝对抗泼尼松不良反应的实验研究[J].中国中医药科技,1996,3(4):16-19. 被引量:16
  • 3李姝玉,胡大伟.系统性红斑狼疮患者骨质疏松的相关因素[J].中国骨质疏松杂志,2007,13(6):447-450. 被引量:5
  • 4Who Study Group. Assessment of fracture risk and its application to screening for post-menopausal osteoporosis [ M ]. World Health Organ Tech Rep Ser, 1994, 843:1 -129.
  • 5Gordon C. Long-term complications of systemic lupus erythematosus [ J ]. Rheumatology ( Oxford ) ,2002, 41 ( 10 ) : 1095 - 1100.
  • 6Di Munno O, Mzzantini M, Delle Sedie A, et al. Risk factors for osteoporosis in female patients with systemic lupus erythematosus [ J ]. Lupus,2004,13 (9) :724-730.
  • 7van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid induced osteoporosis : a meta2analysis [ J ]. Osteoporos Int,2002,13 (10) :777 -787.
  • 8Sun KH, Yu CL, Tang SJ, et al . Monoclonal anti-doublestranded DNA auto antibody stimulates the expression and release of IL-1beta,IL-6, IL- 8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis[J]. Immunology , 2000 , 99(3) :352 -360.
  • 9Amerio P, Freezolini A, Abeni D, et al . Increased IL-18 in patients with systemic lupus erythematosus : relations with Th-1, Th-2, proinflammatory cytokines and disease activity. IL-18 is a marker of disease activity but does not correlate with proinflammatory cytokines [ J ]. Clin Exp Rheumatol , 2002 ,20(4) :535 -538.
  • 10Franchimont N, Reenaers C, Lambert C, et al . Increased expression of receptor activator of NF-kappaB ligand (RANKL) , its receptor RANK and its decoy receptor osteoprote-gerin in the colon of crohnps disease patients[J]. Clin Exp Immunol , 2004 ,138(3) :491 -498.

共引文献6

同被引文献18

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部